加强联合吸入治疗在慢性气道阻塞性疾病中的认识  

The combined inhaled therapy in chronic obstructive airway disease

作　　者：陈小东[1] 

机构地区：[1]复旦大学附属华山医院呼吸内科,上海200040

出　　处：《世界临床药物》2009年第1期12-14,共3页World Clinical Drug

摘　　要：慢性阻塞性肺疾病(COPD)和哮喘是最常见的慢性气道阻塞性疾病,尽管两者发病机制、诊治措施不尽相同,但气道炎症和气道阻塞是它们的相似点。随着近年临床研究的广泛开展,越来越多的证据支持联合治疗是治疗COPD和哮喘的重要方法。本文综述联合吸入治疗在COPD和哮喘中的应用及临床遇到的一些问题。Chronic obstructive pulmonary disease（COPD） and asthma are the common disease of the lungs in which the airways become narrowed. In contrast to asthma, COPD has the poorly reversible airflow limitation and usually gets progressively worse over time. They also have different treatments, although have similar chronic inflammatory response in the airways. Inhaled therapy, including bronchodilators and steroids, is one of several, often complementary, approaches to COPD and asthma treatment.

关 键 词：慢性阻塞性肺疾病 哮喘 吸入型糖皮质激素 长效Β2受体激动剂 联合吸入治疗 

分 类 号：R562.25[医药卫生—呼吸系统]